Animal studies have shown the beneficial effect of betaine supplementation on reducing body fat, while the data from human studies are controversial and inconsistent. The objective of the present systematic review was to investigate the effects of betaine intervention on treating obesity in humans and quantitatively evaluate the pooled effects based on randomized controlled trials with a meta-analysis. The PubMed and Scopus databases, and the Cochrane Library, were searched up to September 2019. Weighted mean differences were calculated for net changes in obesity-related indices by using a random-effects model. Publication bias was estimated using Begg's test. Six studies with 195 participants were identified. Betaine supplementation significantly reduced the total body fat mass (−2.53 kg; 95% CI: −3.93, −0.54 kg; I 2 = 6.6%, P = 0.36) and body fat percentage (−2.44%; 95% CI: −4.20, −0.68%; I 2 = 0.0%, P = 0.44). No changes were observed regarding body weight (−0.29 kg; 95% CI: −1.48, 0.89 kg; I 2 = 0.00%, P = 0.99) and body mass index (−0.10 kg/m 2 ; 95% CI: −5.13, 0.31 kg/m 2 ; I 2 = 0.00%, P = 0.84). The results suggested that dietary betaine supplementation might be an effective approach for reducing body fat.
Introduction
Excess body fat accumulating in the body leads to obesity, which is recognized as a chronic disease and is correlated with multiple health problems, such as type 2 diabetes, cardiovascular diseases, and cancers [1, 2] . Over the past decades, the prevalence of overweight and obesity has increased substantially and now affects over 600 million people worldwide [3] . Currently, effective weight reduction and maintenance strategies, such as lifestyle modification or dietary intervention have been paid increasing attention. Of these, supplementary dietary nutrients from natural products have achieved a great performance in the prevention of obesity.
Betaine is a zwitterionic quaternary ammonium compound, a methyl derivative of glycine and a byproduct isolated from molasses during sugar beets refinement. In addition to sugar beets, betaine is abundant in many other foods, such as spinach, whole grains and seafood. In adults, daily average betaine intake is approximately 100-400 mg [4] . When healthy subjects orally take betaine, it is freely filtered in the kidney, re-absorbed into the blood circulation, and either absorbed and stored in tissues as an organic osmolyte to protect cells under stress or as a catabolic source of methyl groups via transmethylation of homocysteine (Hcy) [5] . In addition to direct dietary intake of betaine or betaine-containing foods, humans can also obtain betaine via choline oxidation in the liver and kidney [6] . To date, numerous studies have discussed the relationships between betaine treatment 
The Characteristics of Inclusive Studies
The basic information of the included studies is listed in Table 1 . Three trials were conducted in USA [18, 20, 21] , and three other trials were carried out in Finland [15, 17] , and Brazil [16] , respectively. Two trials used training programs during the betaine supplementation period [18, 20] and four others were instructed not to exercise [15] [16] [17] 21] . On the basis of Jadad scoring criteria, five trials were regarded as high-quality. 
Betaine Supplementation and Obesity-Related Indices
Five independent trials reported the effect of supplemental betaine on body weight [15] [16] [17] 20, 21] . The pool effect showed betaine supplementation led to no change in body weight (−0.29 kg; 95% CI: −1.48, 0.89 kg; I 2 = 0.00%, P for heterogeneity = 0.99) ( Figure 2 ). Three trials reported the effect of supplemental betaine on BMI [15, 17, 21] , and the pooled effect was non-significant (−0.10 kg/m 2 ; 95% CI: −5.1, 0.31 kg/m 2 ; I 2 = 0.00%, P for heterogeneity = 0.84) ( Figure 3 ). Two trials reported the effect of supplemental betaine on waist circumference [15, 21] , and no change was observed on the pooled effect (0.68 cm; 95% CI: −1.72, 3.09 cm; I 2 = 0.00%, P for heterogeneity = 0.83). Abbreviations: F, female; M, male; No., number of included subjects.
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Publication Bias
Results from Begg's rank correlation test indicated that no obvious publication bias was detected in the meta-analysis of body weight (P = 1.000), BMI (P =1.000), total body fat mass (P = 0.734) and total body fat percentage (P = 1.000) ( Table 2 ). 
Discussion
The effects of betaine on obesity and body composition have been discussed for decades and inconsistent results have been acquired from limited human studies [19] . To our knowledge, this is the first meta-analysis of RCT studies regarding the effect of betaine on obesity in humans. The results showed that supplemental betaine significantly reduced the total body fat mass and percentage in humans, but it had no significant effects on body weight and BMI.
Obesity is a status of excess body fat accumulated in the body. Numerous indices have been employed to evaluate obesity, including body weight, BMI, waist circumference and body 
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Discussion
Obesity is a status of excess body fat accumulated in the body. Numerous indices have been employed to evaluate obesity, including body weight, BMI, waist circumference and body composition, etc. However, body weight, BMI, and waist circumference could not distinguish body lean or obese mass, leading to the limitation of accurately accessing obesity based on these criteria. Body composition, which provides the data of body fat mass and percentage, is recognized as the most accurate index to access obesity [28, 29] . Betaine is a commonly used additive in animal's feed and has been proven to decrease fat mass and increase lean mass in pigs [30, 31] and chickens [13, 32] . Studies in rodents also indicated a significant effect of betaine on improving body composition [11] . Consistent with these results from animals, the current review supports the findings that betaine might be used as potential dietary supplementation to improve body composition in humans. In the present meta-analysis, significant reductions in body fat mass and percentage were observed, indicating an improved effect of betaine on body composition in humans. Cholewa et al. also demonstrated that betaine supplementation significantly increased lean mass in a clinical trial [18] . Decreasing body fat and increasing lean mass may explain the unchanged body weight and BMI after betaine intervention. It should be noticed that only two studies reported significant reductions in body fat, in the existing RCTs, and they were both published by Cholewa et al. [18, 20] . One of the studies had a relatively high weight in the meta-analysis, which might influence the trend of the pooled effects of betaine treatment on body fat, though no publication bias was observed [18] . In addition, the two studies were performed on non-obese young adults going through periodized exercise training programs during betaine intervention. Other RCTs without exercise training did not find significant changes in obesity after betaine treatment [15] [16] [17] 21] . Cholewa et al. also suggested that the significant reduction in body fat in their study might be attributed to the inclusion of exercise in their studies [19] . Moreover, among the six RCTs, only two trials were performed in overweight or obese subjects [15, 21] and the study by Grizales et al. did not measure the body composition of the participants [21] . To reveal the true effect of betaine on excess body fat in humans, more clinical trials should be performed in overweight or obese subjects.
Observational studies support our findings. To date, several cross-sectional studies have investigated the relationships between circulating betaine levels and obesity. A cross-sectional study in Norway showed that plasma betaine levels ware inversely correlated with BMI, waist circumference and body fat percentage in middle age and elderly subjects [33] . Chen et al. found that higher serum levels of betaine were associated with lower body fat and better profiles of body fat distribution in Chinese adults aged 40-75 years [34] . Subsequently, they also found higher serum concentrations of betaine were associated with higher lean mass percentage in the same cohort, particular in males [35] . Our previous study also showed that higher serum betaine levels are associated with better body composition in general adults of Newfoundland [36] . These findings are largely consistent, suggesting that a higher circulating betaine is associated with lower body fat. Serum betaine levels range from 20 to 70 mmol/L [37] in healthy subjects, which are largely affected by dietary food sources of betaine or direct betaine supplements. Levels of blood betaine increase in a dose-dependent manner, and reach a new steady state in a few days following changes in dietary intake of betaine-rich meals [38] . Dietary betaine supplementation also dramatically increased fasting circulating betaine levels [15, 17] . Thus, higher serum betaine levels in subjects with better profiles of body composition may be due to the higher dietary or supplementary betaine intake. To date, only one study has investigated the associations between dietary betaine intake levels and obesity-related indices, which suggested a significant negative relationship [39] .
Considering that the precise mechanisms of dietary betaine protecting against obesity have not been elucidated yet, the possible mechanisms are summarized from in vitro and animal studies as follows ( Figure 6 ). (1) Betaine supplementation could improve lipid lipolysis and reduce lipogenesis. Betaine intervention up-regulated expression of peroxisome proliferator-activated receptor α (PPARα) and downstream fatty acid oxidation-related genes, such as acyl-CoA oxidase 1/2 (ACOX 1/2) [11] . Studies also indicated that betaine increased fatty acid β-oxidation by enhancing muscle carnitine accretion, thus increasing carnitine palmitoyl transferase I-mediated free fatty acid translocation into mitochondria [12, 40] . Betaine can also reduce the capacity for fatty acid and triglyceride synthesis by decreasing the activity of sterol regulatory element-binding protein-1c (SREBP-1c), acetyl-CoA carboxylase (ACC), malic enzyme (ME) and fatty acid synthase (FAS) in adipose tissue [12, 32] and muscle [11] . (2) Betaine decreases uptake of triglycerides from circulating lipoproteins in adipocytes by reducing the expression of lipoprotein lipase (LPL) [32] . (3) Betaine might increase mitochondrial content and activity in hepatocytes [41] and adipocytes [11] , and promote browning of white adipose tissue (WAT) [11] . (4) Betaine supplementation could decrease the levels of homocysteine (Hcy) via transmethylation of Hcy to methionine (Met), which was reported to suppress lipolysis in adipocytes [42] . (5) Betaine promotes protein synthesis. Betaine supplementation stimulates growth hormone (GH) and insulin-like growth factor 1 (IGF-1) secretion and subsequently improves the insulin IRS/Akt-mTOR protein synthetic pathway [31, 43] . Betaine may also increase muscle mass by reducing homocysteine thiolactone (HTL), which is a toxic metabolite of excess homocysteine. HTL can inhibit protein synthesis via suppressing insulin/IGF-1 pathway [44] .
adipose tissue [12, 32] and muscle [11] . (2) Betaine decreases uptake of triglycerides from circulating lipoproteins in adipocytes by reducing the expression of lipoprotein lipase (LPL) [32] . (3) Betaine might increase mitochondrial content and activity in hepatocytes [41] and adipocytes [11] , and promote browning of white adipose tissue (WAT) [11] . (4) Betaine supplementation could decrease the levels of homocysteine (Hcy) via transmethylation of Hcy to methionine (Met), which was reported to suppress lipolysis in adipocytes [42] . (5) Betaine promotes protein synthesis. Betaine supplementation stimulates growth hormone (GH) and insulin-like growth factor 1 (IGF-1) secretion and subsequently improves the insulin IRS/Akt-mTOR protein synthetic pathway [31, 43] . Betaine may also increase muscle mass by reducing homocysteine thiolactone (HTL), which is a toxic metabolite of excess homocysteine. HTL can inhibit protein synthesis via suppressing insulin/IGF-1 pathway [44] . Although our results supported the potential beneficial effect of betaine treatment on reducing body fat, possible contraindications of betaine supplementation should be considered. As a nutrient that can be acquired from either direct dietary intake or oxidation of choline, betaine is not recognized as an essential nutrient. Thus, the recommended daily intake dose and maximum daily intake dose have not been established for betaine. Recent publications indicated that dietary betaine may be metabolized by intestinal microbes to form trimethylamine (TMA), which is subsequently absorbed and metabolized by the hepatic flavin-containing monooxygenase family of enzymes (FMOs) into trimethylamine N-oxide (TMAO) [45] . TMAO is identified as a novel risk factor for cardiovascular disease (CVD) [45] . In addition, the literature reported that dietary betaine could decrease serum homocysteine levels, which is also a risk factor for CVD [10] . To date, some evidence from observational studies suggested that dietary betaine intakes were associated with increased CVD risk in humans [46] . However, most of the findings indicated that higher betaine intakes were associated with lower risk of CVD [4, 47, 48] . Further interventional studies are needed to verify the safety of betaine supplementation.
Several limitations of this study should be acknowledged. Firstly, the dose of betaine supplementation ranged from 2 to 9.9 g per day, the age of the participants ranged from 21 to 58.9 and the duration of intervention ranged from 10 days to 24 weeks. Due to the limited trials, it was difficult to perform subgroup studies and meta-regression. In addition, visceral fat and central obesity are more related to health compared with total body fat [49] . Moreover, body fat distribution was rarely considered in the existing RCTs. Secondly, only two of the existing RCTs were performed in overweight or obese subjects. However, the others were all conducted in healthy subjects. Although our results supported the potential beneficial effect of betaine treatment on reducing body fat, possible contraindications of betaine supplementation should be considered. As a nutrient that can be acquired from either direct dietary intake or oxidation of choline, betaine is not recognized as an essential nutrient. Thus, the recommended daily intake dose and maximum daily intake dose have not been established for betaine. Recent publications indicated that dietary betaine may be metabolized by intestinal microbes to form trimethylamine (TMA), which is subsequently absorbed and metabolized by the hepatic flavin-containing monooxygenase family of enzymes (FMOs) into trimethylamine N-oxide (TMAO) [45] . TMAO is identified as a novel risk factor for cardiovascular disease (CVD) [45] . In addition, the literature reported that dietary betaine could decrease serum homocysteine levels, which is also a risk factor for CVD [10] . To date, some evidence from observational studies suggested that dietary betaine intakes were associated with increased CVD risk in humans [46] . However, most of the findings indicated that higher betaine intakes were associated with lower risk of CVD [4, 47, 48] . Further interventional studies are needed to verify the safety of betaine supplementation.
Several limitations of this study should be acknowledged. Firstly, the dose of betaine supplementation ranged from 2 to 9.9 g per day, the age of the participants ranged from 21 to 58.9 and the duration of intervention ranged from 10 days to 24 weeks. Due to the limited trials, it was difficult to perform subgroup studies and meta-regression. In addition, visceral fat and central obesity are more related to health compared with total body fat [49] . Moreover, body fat distribution was rarely considered in the existing RCTs. Secondly, only two of the existing RCTs were performed in overweight or obese subjects. However, the others were all conducted in healthy subjects. Therefore, additional RCTs with larger sample sizes, accurate evaluation of body fat distribution and multiple obese statuses should be performed to clarify these associations.
Conclusions
In conclusion, this systematic review and meta-analysis provided further evidence that supplemental betaine could reduce body fat in human subjects. Dietary betaine supplementation might be an effective approach for treatment of obesity and improving body composition. Given the favorable benefits identified through the meta-analysis, additional RCTs with larger sample sizes, comparable doses, wider range of ages and various obese statuses are warranted to make further insights into this topic.
